Tagged with Rovi

Singapore Cerner’s managing director of Southeast Asia, Rebecca LaNasa highlights the key importance that Singapore—as the company’s third office outside the U.S.—serves in implementing and piloting new forms of health care information technology (HIT), while elaborating on how the company’s comprehensive portfolio of solutions can actually help both developed and developing…

Ireland Paula O’Neill, co-founder and MD of Premium Power, an Irish electrical consultancy, highlights the importance of having safe, resilient and efficient electrical systems, particularly in high-tech industries like pharmaceutical manufacturing, and her growth strategy for Premium Power in the next few years. Can you give our international audience an introduction…

Mexico Alfredo Gutierrez, general director of Anfitriones, documents the company’s heightened focus on creating a true experience that goes beyond traditional business events and congresses, its expanded geographical reach to Colombia and the upcoming rollout of services to North American companies. Over the last 31 years, Anfitriones has managed to establish…

Mexico Fabiola Trigueros, founder and CEO at Smart Scale, explains the importance of business intelligence capabilities to undertake proper business decisions and showcases the value proposition of Smart Scale to meet the pharmaceutical industry’s needs in this area. After slowing in 2012-13, Mexico’s pharmaceutical sector is expected to grow on average…

Ireland Dermot O’Callaghan, cofounder and Director of Business Development, tells us the exciting story behind the genesis of Enterprise System Partners, an Irish success story providing manufacturing execution systems (MES) and serialization solutions to the pharmaceutical, biotechnology and medical devices industries. He outlines how the industry within Ireland has grown along…

Pharma János Burovincz, Managing Director of Patent, shares his insights on building a company from scratch, the importance of maintaining a diverse portfolio that can quickly adapt to market needs as well as his priorities going forward to continue growing the company’s footprint in Hungary. He also discusses the company’s strong…

Pharma Soneas MD Jozsef Repasi discusses the shift back towards Central and Eastern Europe for contract manufacturing services, the company’s growth since separating from Ubichem, and his ambitions for Soneas to become a fully integrated, end-to-end service provider. As an introduction for our readers, can you please shed some insight into…

Pharma Janssen Czech Republic’s MD reviews his longstanding career within the company and highlights how founder Dr. Paul Janssen’s legacy still influences operations today. He also compares the Czech regulatory environment with those of its regional neighbors and finds that there is little ground for fair comparison. You have been with…

pharma The managing director of Adcock Ingram’s prescription business, Ashley Pearce highlights the division’s strategic placement within the group’s overall activities, and how he plans on leveraging partnerships with various multinationals, expand into biosimilars and grow the generics business into a market leading position. Adcock Ingram has undergone several strategic changes…